JP2022512208A5 - - Google Patents

Info

Publication number
JP2022512208A5
JP2022512208A5 JP2021533261A JP2021533261A JP2022512208A5 JP 2022512208 A5 JP2022512208 A5 JP 2022512208A5 JP 2021533261 A JP2021533261 A JP 2021533261A JP 2021533261 A JP2021533261 A JP 2021533261A JP 2022512208 A5 JP2022512208 A5 JP 2022512208A5
Authority
JP
Japan
Prior art keywords
bedaquiline
pharmaceutical composition
infection
polyoxyethylene
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021533261A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512208A (ja
JP7654544B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/065144 external-priority patent/WO2020123336A1/en
Publication of JP2022512208A publication Critical patent/JP2022512208A/ja
Publication of JP2022512208A5 publication Critical patent/JP2022512208A5/ja
Priority to JP2025044374A priority Critical patent/JP2025098105A/ja
Application granted granted Critical
Publication of JP7654544B2 publication Critical patent/JP7654544B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021533261A 2018-12-13 2019-12-09 ベダキリンの組成物、それらを含む組み合わせ、それらを調製するための方法、それらを含む使用及び治療方法 Active JP7654544B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025044374A JP2025098105A (ja) 2018-12-13 2025-03-19 ベダキリンの組成物、それらを含む組み合わせ、それらを調製するための方法、それらを含む使用及び治療方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862778953P 2018-12-13 2018-12-13
US62/778,953 2018-12-13
PCT/US2019/065144 WO2020123336A1 (en) 2018-12-13 2019-12-09 Compositions of bedaquiline, combinations comprising them, processes for their preparation, uses and methods of treatment comprising them

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025044374A Division JP2025098105A (ja) 2018-12-13 2025-03-19 ベダキリンの組成物、それらを含む組み合わせ、それらを調製するための方法、それらを含む使用及び治療方法

Publications (3)

Publication Number Publication Date
JP2022512208A JP2022512208A (ja) 2022-02-02
JP2022512208A5 true JP2022512208A5 (cg-RX-API-DMAC10.html) 2022-12-19
JP7654544B2 JP7654544B2 (ja) 2025-04-01

Family

ID=69167904

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021533261A Active JP7654544B2 (ja) 2018-12-13 2019-12-09 ベダキリンの組成物、それらを含む組み合わせ、それらを調製するための方法、それらを含む使用及び治療方法
JP2025044374A Pending JP2025098105A (ja) 2018-12-13 2025-03-19 ベダキリンの組成物、それらを含む組み合わせ、それらを調製するための方法、それらを含む使用及び治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025044374A Pending JP2025098105A (ja) 2018-12-13 2025-03-19 ベダキリンの組成物、それらを含む組み合わせ、それらを調製するための方法、それらを含む使用及び治療方法

Country Status (3)

Country Link
US (1) US20220023282A1 (cg-RX-API-DMAC10.html)
JP (2) JP7654544B2 (cg-RX-API-DMAC10.html)
WO (1) WO2020123336A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024511419A (ja) * 2021-03-24 2024-03-13 インスメッド インコーポレイテッド 非結核性抗酸菌肺疾患を治療するための併用療法
WO2023150747A1 (en) * 2022-02-07 2023-08-10 Insmed Incorporated Dry powder compositions of bedaquiline and salts and methods of use thereof
CN116327743B (zh) * 2023-04-13 2024-10-29 南京芩领医药科技有限公司 黄芩素吸入制剂在制备急性肺损伤治疗药物中的应用
WO2024242630A1 (en) * 2023-05-24 2024-11-28 Asg Inspiration Laboratory (Singapore) Pte. Ltd. Pharmaceutical composition for dry powder inhalation and preparation method thereof
WO2025181475A1 (en) * 2024-02-27 2025-09-04 The University Of Liverpool Novel tuberculosis sterilization formulations

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
YU41046B (en) 1974-08-22 1986-10-31 Schering Ag Medicine inholating device
US4268460A (en) 1977-12-12 1981-05-19 Warner-Lambert Company Nebulizer
US4263907A (en) 1979-05-14 1981-04-28 Lindsey Joseph W Respirator nebulizer
US4649911A (en) 1983-09-08 1987-03-17 Baylor College Of Medicine Small particle aerosol generator for treatment of respiratory disease including the lungs
US4624251A (en) 1984-09-13 1986-11-25 Riker Laboratories, Inc. Apparatus for administering a nebulized substance
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
US5164740A (en) 1991-04-24 1992-11-17 Yehuda Ivri High frequency printing mechanism
DE59108798D1 (de) 1991-11-07 1997-08-28 Ritzau Pari Werk Gmbh Paul Vernebler insbesondere zur Anwendung in Geräten für die Inhalationstherapie
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US5709202A (en) 1993-05-21 1998-01-20 Aradigm Corporation Intrapulmonary delivery of aerosolized formulations
DE69535897D1 (de) 1994-03-07 2009-01-22 Nektar Therapeutics Verfahren und Zusammensetzung für die pulmonale Darreichung von Insulin
US5586550A (en) 1995-08-31 1996-12-24 Fluid Propulsion Technologies, Inc. Apparatus and methods for the delivery of therapeutic liquids to the respiratory system
US5758637A (en) 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US5906202A (en) 1996-11-21 1999-05-25 Aradigm Corporation Device and method for directing aerosolized mist to a specific area of the respiratory tract
US6001336A (en) 1996-12-31 1999-12-14 Inhale Therapeutic Systems Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof
US6349719B2 (en) 1997-02-24 2002-02-26 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
US5855564A (en) 1997-08-20 1999-01-05 Aradigm Corporation Aerosol extrusion mechanism
JP2001518494A (ja) 1997-10-08 2001-10-16 セプレイサー インコーポレイテッド エアゾル投与用の投薬形態
DK1129741T3 (da) 1997-11-19 2006-08-07 Microflow Eng Sa Forstövningsindretning til inhalator
US6192876B1 (en) 1997-12-12 2001-02-27 Astra Aktiebolag Inhalation apparatus and method
GB2343122B (en) 1998-10-26 2003-01-08 Medic Aid Ltd Improvements in and relating to nebulisers
US6070575A (en) 1998-11-16 2000-06-06 Aradigm Corporation Aerosol-forming porous membrane with certain pore structure
US6584971B1 (en) 1999-01-04 2003-07-01 Medic-Aid Limited Drug delivery apparatus
US6338443B1 (en) 1999-06-18 2002-01-15 Mercury Enterprises, Inc. High efficiency medical nebulizer
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
DE10004465A1 (de) 2000-02-02 2001-08-16 Pari Gmbh Inhalationsvernebler
CA2826724C (en) 2000-04-11 2016-02-02 Trudell Medical International Aerosol delivery apparatus with positive expiratory pressure capacity
GB0014869D0 (en) 2000-06-16 2000-08-09 Glaxo Group Ltd Novel pharmaceutical formulation
US6601581B1 (en) 2000-11-01 2003-08-05 Advanced Medical Applications, Inc. Method and device for ultrasound drug delivery
DE10126807C2 (de) 2001-06-01 2003-12-04 Pari Gmbh Inhalationstherapiegerät mit einem Ventil zur Begrenzung des Inspirationsflusses
DE10348237A1 (de) 2003-10-16 2005-05-19 Pari GmbH Spezialisten für effektive Inhalation Inhalationstherapievorrichtung mit einem Düsenvernebler
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
EP1927373B1 (en) 2006-11-30 2012-08-22 PARI Pharma GmbH Inhalation nebulizer
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
DE102008022987A1 (de) 2008-05-09 2009-11-12 Pari Pharma Gmbh Vernebler für Beatmungsmaschinen und Beatmungsmaschine mit einem solchen Vernebler
US9975136B2 (en) 2011-06-08 2018-05-22 Pari Pharma Gmbh Aerosol generator
GB2510407A (en) 2013-02-04 2014-08-06 Kalvista Pharmaceuticals Ltd Aqueous suspensions of kallikrein inhibitors for parenteral administration
WO2015179369A1 (en) * 2014-05-20 2015-11-26 Infinity Pharmaceuticals, Inc. Treatment of pulmonary or respiratory diseases by inhalation administration of pi3 kinase inhibitors
WO2016005440A1 (en) * 2014-07-09 2016-01-14 Arven Ilac Sanayi Ve Ticaret A.S. A process for the preparation of dry powder formulations
CN107249691A (zh) * 2014-11-03 2017-10-13 加利福利亚大学董事会 用于肺结核治疗的多药疗法
KR102631986B1 (ko) 2015-01-27 2024-01-30 얀센 파마슈티카 엔브이 분산성 조성물
AU2018298855B2 (en) * 2017-07-14 2024-07-18 Janssen Pharmaceutica Nv Long-acting formulations

Similar Documents

Publication Publication Date Title
KR101646079B1 (ko) 트립탄 화합물을 포함하는 제제
JP2019203032A (ja) 経肺投与によって心疾患を治療するための単位用量、エアロゾル、キット、および方法
US20180042944A1 (en) Pharmaceutical compositions
JP7798858B2 (ja) コロナウイルス感染症の治療のための化合物
JP2019069978A (ja) Ｒｐｌ５５４を含む液体吸入製剤
JP7654544B2 (ja) ベダキリンの組成物、それらを含む組み合わせ、それらを調製するための方法、それらを含む使用及び治療方法
JP2017509684A5 (cg-RX-API-DMAC10.html)
MX2014001345A (es) Metodo y formulacion para inhalacion.
US11857597B2 (en) Lipo-glycopeptide cleavable derivatives and uses thereof
US20090208581A1 (en) Formulations limiting spread of pulmonary infections
JP2020528928A (ja) ジピベフリンの使用方法
JP2021517558A (ja) 特発性肺線維症を治療するための方法および組成物
JPH06504991A (ja) 組成物
CA2963085A1 (en) An inhalable rapamycin formulation for the treatment of pulmonary hypertension
KR20240006582A (ko) Alk-5 (tgf 베타 r1) 억제제로 폐 질환을 치료하기 위한 방법
JP2025143385A (ja) クロファジミンの組成物、それを含む組合せ、その調製プロセス、それを含む使用及び処置方法
CN103347518A (zh) 含有抗毒蕈碱药物的无推进剂液体制剂
JP2023540259A (ja) 肺感染症の治療および予防用のグルコシダーゼ阻害剤
JP2023524064A (ja) ウイルス感染を治療又は予防するためのクロファジミン組成物及び方法
JP2013539784A (ja) 嚢胞性線維症の吸入デヌホソルでの治療方法
EP4274577A1 (en) Inhalable imatinib formulation
Merlos et al. Recent developments in inhaled triazoles against invasive pulmonary Aspergillosis
JP2024544075A (ja) ブルーリ潰瘍におけるマイコバクテリウム・ウルセランスの局所治療のための製剤及び方法
HK40111713A (en) Formulation and method for topical treatment of mycobacterium ulcerans in buruli ulcers
KR20180030399A (ko) 네뷸라이저용 조성물